Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
96 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
Rank Status Study
21 Unknown  The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
Conditions: Allergic Rhinitis;   Asthma;   Allergic Conjunctivitis;   Atopic Dermatitis
Intervention:
22 Recruiting Ocular Allergy Treatment Practical Impact Trial
Conditions: Allergic Conjunctivitis;   Rhinoconjunctivitis
Intervention: Drug: Alcaftadine
23 Recruiting Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months
Conditions: Vernal Keratoconjunctivitis;   Healthy Children
Intervention: Procedure: Cytokins assay in tears
24 Not yet recruiting Seasonal Differences in Nasal Mucus Proteome and Impact of Immunotherapy
Condition: Allergic Rhinoconjunctivitis
Intervention: Biological: Immunotherapy
25 Recruiting Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
Condition: Vernal Keratoconjunctivitis
Interventions: Drug: NOVA22007 ''Ciclosporin'';   Drug: Placebo
26 Recruiting MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)
Conditions: Allergic Rhinitis;   Allergic Rhinoconjunctivitis
Interventions: Biological: MK-8237;   Other: Placebo
27 Unknown  Allergic Eye Disease Tear Mediators
Condition: Allergic Eye Disease
Intervention: Drug: olopatadine
28 Not yet recruiting Efficacy and Safety of LAIS® Mites Sublingual Tablets
Condition: Allergic Conditions
Intervention: Drug: LAIS®
29 Recruiting Fluorometholone as Ancillary Therapy for TT Surgery
Conditions: Trichiasis;   Trachoma;   Bilamellar Tarsal Rotation
Interventions: Drug: Fluorometholone 0.1% ophthalmic solution;   Other: Artificial tears (Placebo)
30 Not yet recruiting Nepal Elimination of Trachoma Study
Condition: Trachoma
Intervention: Drug: Azithromycin
31 Recruiting A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
Condition: Trachoma
Intervention: Other: Surveillance and treatment with azithromycin of newcomer and traveler families
32 Recruiting Paediatric Safety Study in Cat-PAD
Condition: Rhinoconjunctivitis
Interventions: Drug: Cat-PAD;   Drug: Placebo
33 Recruiting Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
Conditions: Rhinitis;   Rhinoconjunctivitis;   Asthma
Interventions: Biological: DP/MG/14-1;   Biological: DP/MG/14-2
34 Recruiting Grass Observational Study
Conditions: Grass Allergy;   Rhinoconjunctivitis
Intervention:
35 Recruiting Phase II HDM-SPIRE Safety and Efficacy Study
Condition: Rhinoconjunctivitis
Interventions: Drug: HDM-SPIRE;   Drug: Placebo
36 Recruiting Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye
Condition: Dry Eye Syndromes
Intervention: Device: Oculeve Intranasal Lacrimal Neurostimulator
37 Not yet recruiting Estrogen and the Outer Eye in Women During Fertility Treatment
Condition: Dry Eye Syndromes
Intervention:
38 Recruiting A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
Condition: Dry Eye Syndromes
Interventions: Drug: TheraTears® Lubricant Eye Drop;   Drug: TheraTears® preservative-free single-use containers;   Dietary Supplement: TheraTears® Nutrition;   Other: TheraTears® TheraLid® Eyelid Cleanser
39 Recruiting Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Syndrome
Intervention: Drug: dexamethasone, artificial tears
40 Recruiting Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
Condition: Dry Eye Syndrome
Interventions: Drug: cis-UCA ophthalmic solution 1.0%;   Drug: cis-UCA ophthalmic solution 2.5%;   Drug: Placebo ophthalmic solution

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years